A success story based on a recent clinical observational study done in Canada. This time a young man with BRAF-positive, stage III recurrent melanoma, which failed to respond to a handful conventional treatments, managed to control his skin cancer with the help of DCA. Learn more about how he continued living a normal life while experiencing no debilitation.